Representative Publications

View All Publications

Elsaid MY, Capitini CM, Diamond CA, Porte M, Otto M, DeSantes KB. Successful matched unrelated donor stem cell transplant in Hemoglobin Bart's disease. Bone marrow transplantation. 2016; 51(11):1522-1523. PubMed PMID: 27295273, PMCID: PMC5096454

Jiao P, Otto M, Geng Q, Li C, Li F, Butch ER, Snyder SE, Zhou H, Yan B. Enhancing both CT imaging and natural killer cell-mediated cancer cell killing by a GD2-targeting nanoconstruct. J Mater Chem B Mater Biol Med. 2016 Jan 20;4(3):513-520. PubMed PMID: 27087966, PMCID: PMC4830492.

Marino R, Baiu DC, Bhattacharya S, Titz B, Hebron E, Menapace BD, Singhal S, Eickhoff JC, Asimakopoulos F, Weichert JP, Otto M. Tumor-selective anti-cancer effects of the synthetic alkyl phosphocholine analog CLR1404 in neuroblastoma. American journal of cancer research. 2015; 5(11):3422-35. PubMed PMID: 26807322, PMCID: PMC4697688

Baiu DC, Artz NS, McElreath MR, Menapace BD, Hernando D, Reeder SB, Grüttner C, Otto M. High specificity targeting and detection of human neuroblastoma using multifunctional anti-GD2 iron-oxide nanoparticles. Nanomedicine (London, England). 2015; PubMed PMID: 26420448, PMCID: PMC4814363

McDowell KA, Hank JA, DeSantes KB, Capitini CM, Otto M, Sondel PM. NK cell-based  immunotherapies in Pediatric Oncology. Journal of pediatric hematology/oncology.  2015; 37(2):79-93. PubMed PMID: 25590232, PMCID: PMC4429888

Navid F, Sondel PM, Barfield R, Shulkin BL, Kaufman RA, Allay JA, Gan J, Hutson P, Seo S, Kim K, Goldberg J, Hank JA, Billups CA, Wu J, Furman WL, McGregor LM, Otto M, Gillies SD, Handgretinger R, Santana VM. Phase I trial of a novel anti-GD2 monoclonal antibody, Hu14.18K322A, designed to decrease toxicity in children with refractory or recurrent neuroblastoma. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2014; 32(14):1445-52. PubMed PMID: 24711551, PMCID: PMC4017710

Xu Y, Baiu DC, Sherwood JA, McElreath MR, Qin Y, Lackey KH, Otto M, Bao Y. Linker-free conjugation and specific cell targeting of antibody functionalized iron-oxide nanoparticles. J Mater Chem B Mater Biol Med. 2014 Oct 7;2(37):6198-6206. PubMed PMID: 26660881; PMCID: PMC4675334.

Capitini CM, Otto M, DeSantes KB, Sondel PM. Immunotherapy in pediatric malignancies: current status and future perspectives. Future oncology (London, England). 2014; 10(9):1659-78. PubMed PMID: 25145434, PMCID: PMC4793725

Baiu DC, Brazel CS, Bao Y, Otto M. Interactions of iron oxide nanoparticles with the immune system: challenges and opportunities for their use in nano-oncology. Current pharmaceutical design. 2013; 9(37):6606-21. PubMed PMID: 23621531

Otto M, Shulkin BL, Kundu M, Sandlund JT, Snyder SE, Metzger ML. Histiocyte-rich  xanthomatous pseudotumor mimicking relapse on positron emission tomography imaging in an adolescent with primary mediastinal diffuse large B-cell lymphoma.  Journal of pediatric hematology/oncology. 2012; 34(3):232-5. PubMed PMID: 22082744